Sign In
Buy NVO
$47.41
-0.0100 (-0.0211%)
At Close: Jun 24, 2026
Novo Nordisk: A Pill For Growth
05:49pm, Thursday, 08'th Jan 2026
Novo Nordisk is rated Buy, with the FDA-approved Wegovy pill seen as a potential catalyst to reignite growth and recapture market share. NVO faces headwinds from lower pill pricing, potential cannibal
Novo Nordisk: My Top Pick For 2026
12:35pm, Thursday, 08'th Jan 2026
Novo Nordisk: My Top Pick For 2026
3 of the Best Stocks Under $100 to Buy in 2026
08:55am, Thursday, 08'th Jan 2026
These stocks are big names in their respective industries, and their prices make them look like bargain buys.
First Look: Apple-JPM card deal, Ford L3, defense clampdown
07:38am, Thursday, 08'th Jan 2026
Stock News Trump targets Wall Street homebuying: President Trump proposed banning large institutional investors from purchasing single-family homes, sending sha
Market Today: Trump Housing Ban, Apple Card Shift, ISM Jump
05:34pm, Wednesday, 07'th Jan 2026
Guru Stock PicksRon Baron has made the following transactions:Add in CHH by 39.44%Manning and Napier Group, LLC has made the following transactions:Reduce in RMOP
First Look: Nvidia, Ford, Novo Nordisk and Hyundai in Focus
07:39am, Wednesday, 07'th Jan 2026
Stock News WBD sticks with Netflix deal: Warner Bros. Discovery (WBD) again rejected Paramount's (PARA) hostile bid, reaffirming its $72B agreement to sell its
Ventyx (VTYX) Shares Soar 62.5% Overnight, Here's What's Going On With This Trending Stock
10:14pm, Tuesday, 06'th Jan 2026
Ventyx shares jumped in after-hours trading following reports that Eli Lilly is in advanced talks to acquire the biopharma company for over $1 billion.
Should Investors Be Concerned About This Pharmaceutical Giant's Latest Clinical Trial?
06:00pm, Tuesday, 06'th Jan 2026
Novo Nordisk has released a pill version of its GLP-1 drug. In 2025, the company announced that it was ending a GLP-1 trial related to the drug's impact on Alzheimer's.
Market Today: Records, robots, obesity pill, and AI tie-ups
05:35pm, Tuesday, 06'th Jan 2026
Stock News Regulators press X over Grok deepfakes: UK authorities and EU officials demanded action after reports that X's Grok chatbot generated nonâconsensua
Can the US Launch of NVO's Wegovy Pill Reignite Momentum in 2026?
10:45am, Tuesday, 06'th Jan 2026
Novo Nordisk shares jump after the U.S. launch of its FDA-approved Wegovy pill, giving the first oral GLP-1 weight-loss drug a chance to revive 2026 momentum.
Novo Nordisk: NVO Stock To $100?
09:10am, Tuesday, 06'th Jan 2026
Novo Nordisk's (NYSE: NVO) Wegovy pill introduction in the U.S. may serve as the turning point that transforms a beleaguered GLP‑1 leader into a viable 2x story moving forward, provided it effective
First Look: Nvidia's Rubin, Wegovy pill, RTX radar upgrade lead
07:39am, Tuesday, 06'th Jan 2026
Stock News U.S. weighs reimbursing Venezuela oil rebuild: President Trump said the U.S. may reimburse oil companies like Exxon Mobil (XOM), Chevron (CVX) and Co
Novo Nordisk A/S $NVO Shares Sold by Merit Financial Group LLC
05:32am, Tuesday, 06'th Jan 2026
Merit Financial Group LLC reduced its stake in shares of Novo Nordisk A/S (NYSE: NVO) by 66.7% during the undefined quarter, according to the company in its most recent 13F filing with the Securities
Final Trade: NVO, JPM, COST, MPC
06:15pm, Monday, 05'th Jan 2026
The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders.
Market Today: Dow Record on Energy Rally; Novo Pill, AT&T Move
05:34pm, Monday, 05'th Jan 2026
Stock News Dow hits record as energy, banks surge: U.S. stocks advanced with the Dow topping 49,000 as oil names rallied after U.S. action in VenezuelaâChevro
